Tinnitus Patient Preferences Survey

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Individuals aged 18 or older suffering from subjective tinnitus

• Self-reported or healthcare professional-diagnosed chronic (lasting 3 months or longer), subjective, burdensome tinnitus

Locations
United States
New York
Neurosoft Bielectronics US Inc.
RECRUITING
New York
Contact Information
Primary
Nicolas Gninenko, PhD
clinical@neurosoft-bio.com
000-000-0000
Time Frame
Start Date: 2025-01-13
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 500
Treatments
patients with tinnitus
Related Therapeutic Areas
Sponsors
Leads: Nicolas Gninenko

This content was sourced from clinicaltrials.gov